These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16924645)

  • 1. Successful control of severe postoperative bleeding with recombinant factor VIIa in a case of refractory idiopathic thrombocytopenic purpura.
    Aguilar C; Lucía JF
    Am J Hematol; 2007 Mar; 82(3):246-7. PubMed ID: 16924645
    [No Abstract]   [Full Text] [Related]  

  • 2. Experiences with recombinant activated factor VII in the treatment of severe refractory thrombocytopenia.
    Wróbel G; Dobaczewski G; Patkowski D; Sokół A; Grotthus E
    Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):729-30. PubMed ID: 16933258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recombinant factor VII-a--new possibility for the treatment of severe postpartal bleeding--literature review].
    Katsulov A; Getskovski T; Iankov M; Kirova N
    Akush Ginekol (Sofiia); 2004; 43(5):44-6. PubMed ID: 15518285
    [No Abstract]   [Full Text] [Related]  

  • 4. Thromboelastometry to guide recombinant activated factor VII therapy for postoperative refractory intracranial bleeding.
    Hirasaki Y; Suematsu Y; Yasuda T; Tajima K
    Anesth Analg; 2010 Jan; 110(1):261-2. PubMed ID: 20023190
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful treatment with recombinant factor VIIa for intractable bleeding at pelvic surgery.
    Daniloś J; Goral A; Paluszkiewicz P; Przesmycki K; Kotarski J
    Obstet Gynecol; 2003 Jun; 101(6):1172-3. PubMed ID: 12798520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Application of recombinant activated factor VII in gynecological intervention (case report)].
    Nacheva A; Gateva Zh; Atanasova V
    Akush Ginekol (Sofiia); 2004; 43 Suppl 4():3-5. PubMed ID: 15673003
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful use of recombinant factor VIIa in a patient with acquired Glanzmann thrombasthenia.
    Tuffigo M; Lazaro E; James C; Subtil C; Viallard JF; Fiore M
    Haemophilia; 2015 Jan; 21(1):e116-8. PubMed ID: 25471665
    [No Abstract]   [Full Text] [Related]  

  • 8. Bleeding and surgery in children with Glanzmann thrombasthenia with and without the use of recombinant factor VII a.
    Hennewig U; Laws HJ; Eisert S; Göbel U
    Klin Padiatr; 2005; 217(6):365-70. PubMed ID: 16307424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of recombinant-activated factor VII to successfully control postoperative critical bleeding after emergency repair of ruptured abdominal aortic aneurysm in a noncoagulopathic patient.
    Dell'Utri D; Passariello M
    J Cardiothorac Vasc Anesth; 2006 Aug; 20(4):570-2. PubMed ID: 16884992
    [No Abstract]   [Full Text] [Related]  

  • 10. Con: The role of recombinant factor VIIa in the control of bleeding after cardiac surgery.
    Al-Ruzzeh S; Ibrahim K; Navia JL
    J Cardiothorac Vasc Anesth; 2008 Oct; 22(5):783-5. PubMed ID: 18922443
    [No Abstract]   [Full Text] [Related]  

  • 11. Thromboelastography-guided recombinant factor VIIa administration in a patient with refractory autoimmune idiopathic thrombocytopenia.
    James KM; Melikian CN; Chowdary P; Mallett SV
    Anesth Analg; 2008 Aug; 107(2):402-5. PubMed ID: 18633015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Activated recombinant factor VII for bleeding after a kidney transplant: reflections].
    Pajares A; Larrea L
    Rev Esp Anestesiol Reanim; 2006 Apr; 53(4):266-7; author reply 268. PubMed ID: 16711505
    [No Abstract]   [Full Text] [Related]  

  • 13. Recombinant activated factor VII in the management of massive obstetric bleeding.
    Palomino MA; Chaparro MJ; de Elvira MJ; Curiel EB
    Blood Coagul Fibrinolysis; 2006 Apr; 17(3):226-7. PubMed ID: 16575264
    [No Abstract]   [Full Text] [Related]  

  • 14. Low-dose recombinant factor VIIa in the management of uncontrolled postoperative hemorrhage in cardiac surgery patients.
    van de Garde EM; Bras LJ; Heijmen RH; Knibbe CA; van Dongen EP; Wiltink EH; Biesma DH
    J Cardiothorac Vasc Anesth; 2006 Aug; 20(4):573-5. PubMed ID: 16884993
    [No Abstract]   [Full Text] [Related]  

  • 15. Sequential therapy with activated prothrombin complex concentrate (FEIBA) and recombinant factor VIIa in a patient with severe haemophilia A, inhibitor presence and refractory bleeding.
    Economou M; Teli A; Tzantzaroudi A; Tsatra I; Zavitsanakis A; Athanassiou-Metaxa M
    Haemophilia; 2008 Mar; 14(2):390-1. PubMed ID: 18194305
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment and prevention of haemorrhage with recombinant activated factor VII, not only in hemophilia].
    Gielen-Wijffels SE; van Mook WN; Ramsay G
    Ned Tijdschr Geneeskd; 2003 Mar; 147(9):419. PubMed ID: 12661464
    [No Abstract]   [Full Text] [Related]  

  • 17. Recombinant factor VIIa is a pan-hemostatic agent?
    Aledort LM
    Thromb Haemost; 2000 May; 83(5):637-8. PubMed ID: 10823252
    [No Abstract]   [Full Text] [Related]  

  • 18. Continuous infusion of recombinant factor VIIa: continue or not?
    Ewenstein BM
    Thromb Haemost; 2001 Oct; 86(4):942-4. PubMed ID: 11686349
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of recombinant factor VIIa in severe postpartum hemorrhage.
    Segal S; Shemesh IY; Blumental R; Yoffe B; Laufer N; Mankuta D; Mazor M; Zohar S; Schiff E; Martinovitz U
    Acta Obstet Gynecol Scand; 2004 Aug; 83(8):771-2. PubMed ID: 15255852
    [No Abstract]   [Full Text] [Related]  

  • 20. Caution with the use of recombinant activated factor VII in treating postoperative hemorrhage in cardiac surgery.
    Al-Ruzzeh S; Mahmoud A; Shah S; O'Regan D
    Ann Thorac Surg; 2007 Jan; 83(1):355; author reply 355-6. PubMed ID: 17184710
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.